NCT04550494 2026-03-19
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
Phase 2 Recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
OHSU Knight Cancer Institute
Mayo Clinic
Emory University
National Cancer Institute (NCI)
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI)